Seragen Inc Sample Contracts

AutoNDA by SimpleDocs
between
License Agreement • June 10th, 1997 • Seragen Inc • Biological products, (no disgnostic substances) • Tokyo
AMENDMENT 4 CONSULTING AGREEMENT
Consulting Agreement • August 15th, 1997 • Seragen Inc • Biological products, (no disgnostic substances)
WAIVER AGREEMENT
Waiver Agreement • March 31st, 1998 • Seragen Inc • Biological products, (no disgnostic substances)

This Waiver Agreement is made as of October 28, 1997, by and between Boston University, Leon C. Hirsch, Turi Josefsen, Gerald S.J. Cassidy and Loretta P. Cassidy (individually, a "Stockholder" and collectively, the "Stockholders"), Reed R. Prior ("Prior"), and Seragen, Inc. (the "Company").

The Seller shall transfer the Transferred Assets to the Buyer pursuant to a bill of sale substantially in the form of Exhibit 1.01 attached hereto -2-
Asset Purchase Agreement • March 5th, 1997 • Seragen Inc • Biological products, (no disgnostic substances) • Massachusetts
SERAGEN, INC. 97 South Street Hopkinton, MA 01748
Letter Agreement • November 14th, 1996 • Seragen Inc • Biological products, (no disgnostic substances)
SERAGEN, INC.
Asset Purchase Agreement • November 7th, 1997 • Seragen Inc • Biological products, (no disgnostic substances)
AutoNDA by SimpleDocs
WITNESSETH:
License Agreement • June 10th, 1997 • Seragen Inc • Biological products, (no disgnostic substances)
Exhibit No. 10.69 WAIVER
Seragen Inc • April 2nd, 1997 • Biological products, (no disgnostic substances)

Reference is made to the Employment Agreement dated as of November 6, 1996 between Seragen, Inc. (the "Company") and the undersigned, as amended by an Amendment No. 1 to Employment Agreement dated as of December 18, 1996 between the Company and the undersigned (together the "Agreement"). Pursuant to the Agreement, the Company agreed to file a registration statement on Form S-8 (the "Registration Statement") registering under the Securities Act of 1993 all shares issued or to be issued pursuant to the exercise of the stock options granted to Nichols pursuant to the Agreement on or before January 6, 1997.

WAIVER Reference is made to the Amended and Restated Employment Agreement dated as of September 22, 1997 between Seragen, Inc. (the "Company") and the undersigned (the "Agreement"). Pursuant to the Agreement, the Company agreed to file on or before...
Employment Agreement • March 31st, 1998 • Seragen Inc • Biological products, (no disgnostic substances)

Reference is made to the Amended and Restated Employment Agreement dated as of September 22, 1997 between Seragen, Inc. (the "Company") and the undersigned (the "Agreement"). Pursuant to the Agreement, the Company agreed to file on or before December 31, 1997, a registration statement on Form S-8 (the "Registration Statement") registering under the Securities Act of 1993 all shares issued or to be issued pursuant to the exercise of the stock options granted to Dr. Nichols pursuant to the Agreement.

WAIVER NO. 3 Reference is made to the Employment Agreement dated as of January 15, 1997 between Seragen, Inc. (the "Company") and the undersigned, as amended (collectively the "Agreement"). Pursuant to the Agreement and subsequent waivers, the Company...
Seragen Inc • March 31st, 1998 • Biological products, (no disgnostic substances)

Reference is made to the Employment Agreement dated as of January 15, 1997 between Seragen, Inc. (the "Company") and the undersigned, as amended (collectively the "Agreement"). Pursuant to the Agreement and subsequent waivers, the Company agreed to file on or before December 31, 1997, a registration statement on Form S-8 (the "Registration Statement") registering under the Securities Act of 1993 all shares issued or to be issued pursuant to the exercise of the stock options granted to Ms. Chen pursuant to the Agreement.

March 28, 1997 Seragen, Inc. 97 South Street Hopkinton, MA 01748 Re: Employment Agreement Gentlemen: The undersigned hereby confirms that the term "Change in Ownership" as defined in the Employment Agreement dated November 6, 1996 between the...
Seragen Inc • April 2nd, 1997 • Biological products, (no disgnostic substances)

The undersigned hereby confirms that the term "Change in Ownership" as defined in the Employment Agreement dated November 6, 1996 between the undersigned and Seragen, Inc. (the "Company") does not include the sale of the Company's manufacturing and clinical operations facilities to Boston University or Boston University's designated affiliate pursuant to the Assets Purchase Agreement dated as of February 14, 1997 between the Company and Boston University.

WHEREAS, Lilly and Seragen desire to amend the Sales Agreement and the Development Agreement; -5-
Sales and Distribution Agreement and Development Agreement • June 20th, 1997 • Seragen Inc • Biological products, (no disgnostic substances)
Time is Money Join Law Insider Premium to draft better contracts faster.